ABELES JOHN H 4
4 · Medite Cancer Diagnostics, Inc. · Filed Oct 23, 2018
Insider Transaction Report
Form 4
ABELES JOHN H
Director
Transactions
- Purchase
Common Stock
2018-10-11$0.07/sh+266,667$20,000→ 1,566,852 total(indirect: Northlea Partners, Ltd.) - Other
Common Stock
2018-08-13+40,000→ 1,300,185 total(indirect: Northlea Partners, Ltd.)
Holdings
- 116,350
Common Stock
Footnotes (1)
- [F1]40,000 shares were issued to Northlea Partners, Ltd. for accrued interest on a debt.